Design, synthesis, and biological evaluation of pyrazole derivatives containing acetamide bond as potential BRAFV600E inhibitors. 2018

Chen-Ru Wang, and Ze-Feng Wang, and Lu Shi, and Zhong-Chang Wang, and Hai-Liang Zhu
State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210023, People's Republic of China.

With the increasingly acquired resistance, relapse and side effects of known marketed BRAFV600E inhibitors, it's significant to design the more effective and novel drugs. In this study, a series of novel pyrazole derivatives containing acetamide bond had been designed and synthesized on the basis of analysis of the endogenous ligands extracted from the known B-Raf co-crystals in the PDB database. Then, the compounds were evaluated for biological activities as potential BRAFV600E inhibitors. The bioassay results in vitro against three human tumor cell lines revealed that some of the compounds showed very impressed antiproliferative property. Among them, the compound 5r with IC50 values of 0.10 ± 0.01 μM against BRAFV600E and 0.96 ± 0.10 μM against A375 cell line, showed the most potent inhibitory effect, compared with the positive-controlled agents vemurafenib (IC50 = 0.04 ± 0.004 μM for BRAFV600E, IC50 = 1.05 ± 0.10 μM against A375). Further investigation confirmed that the compound 5r could induce A375 cell apoptosis, induce A375 cell death through changing mitochondrial membrane potential, and result in A375 cell arrest at the G1 phase of the cell cycle. Docking simulations results indicated that the compound 5r could bind tightly at the BRAFV600E active site. Meanwhile, 3D-QSAR model suggested that these compounds may be potential anticancer inhibitors. Overall, the article provided some new molecular scaffolds for the further BRAFV600E inhibitors.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000081 Acetamides Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Chen-Ru Wang, and Ze-Feng Wang, and Lu Shi, and Zhong-Chang Wang, and Hai-Liang Zhu
March 2023, Scientific reports,
Chen-Ru Wang, and Ze-Feng Wang, and Lu Shi, and Zhong-Chang Wang, and Hai-Liang Zhu
February 2012, European journal of medicinal chemistry,
Chen-Ru Wang, and Ze-Feng Wang, and Lu Shi, and Zhong-Chang Wang, and Hai-Liang Zhu
March 2021, European journal of medicinal chemistry,
Chen-Ru Wang, and Ze-Feng Wang, and Lu Shi, and Zhong-Chang Wang, and Hai-Liang Zhu
April 2015, European journal of medicinal chemistry,
Chen-Ru Wang, and Ze-Feng Wang, and Lu Shi, and Zhong-Chang Wang, and Hai-Liang Zhu
April 2022, Bioorganic & medicinal chemistry letters,
Chen-Ru Wang, and Ze-Feng Wang, and Lu Shi, and Zhong-Chang Wang, and Hai-Liang Zhu
May 2016, Chemical biology & drug design,
Chen-Ru Wang, and Ze-Feng Wang, and Lu Shi, and Zhong-Chang Wang, and Hai-Liang Zhu
August 2017, Pest management science,
Chen-Ru Wang, and Ze-Feng Wang, and Lu Shi, and Zhong-Chang Wang, and Hai-Liang Zhu
September 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Chen-Ru Wang, and Ze-Feng Wang, and Lu Shi, and Zhong-Chang Wang, and Hai-Liang Zhu
November 2019, Bioorganic chemistry,
Chen-Ru Wang, and Ze-Feng Wang, and Lu Shi, and Zhong-Chang Wang, and Hai-Liang Zhu
December 2016, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!